Skip to main content
. 2021 Feb 2;14(3):1069–1081. doi: 10.1111/cts.12972

FIGURE 3.

FIGURE 3

Comparison of simulated distribution of pevonedistat plasma exposures between (a) BSA‐adjusted dosing and (b) fixed dosing. AUC, area under the concentration‐time curve; BSA, body surface area